Daunorubicin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Daunorubicin. Educational only — not medical advice.
Labeled uses
Daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.
Source: FDA labeling via NIH DailyMed (set f4312095…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.